Medicare Enrolled
Dr. Brandi Fleenor, MD
Neurology · Savannah, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fleenor from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fleenor?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fleenor
Dr. Brandi Fleenor is a neurology specialist in Savannah, GA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Fleenor performed 12,162 Medicare services across 947 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fleenor received a total of $44,445 from 68 pharmaceutical and/or device companies across 663 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fleenor is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 10% volume in GA
$44,445 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,162
Medicare services
Top 10% in GA for neurology
947
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~811 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
11,045 | $5 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
472 | $86 | $327 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
86 | $118 | $450 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
71 | $137 | $2,000 |
| New patient office visit, complex (60-74 min) | 61 | $133 | $536 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
47 | $71 | $300 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
43 | $38 | $200 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
39 | $118 | $423 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
38 | $60 | $150 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
32 | $117 | $891 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
26 | $99 | $300 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $62 | $234 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
23 | $123 | $1,600 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
23 | $126 | $475 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
19 | $93 | $1,200 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
17 | $261 | $1,250 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
17 | $151 | $2,000 |
| MRI of upper spine without contrast An MRI scan of the upper spinal canal that does not use contrast dye. This imaging test uses magnetic fields and radio waves to create detailed pictures of the spine. |
16 | $140 | $2,000 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
16 | $24 | $175 |
| MRI of lower spine, without contrast A magnetic resonance imaging scan of the lower spinal canal that does not use contrast dye to create detailed images of the spine. |
13 | $133 | $2,000 |
| MRI of head blood vessels without contrast An MRI scan that creates detailed images of the blood vessels in the head without using contrast dye. |
11 | $144 | $2,000 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
11 | $225 | $2,800 |
| Needle electromyography of trunk or head muscles A test that uses a needle electrode to measure the electrical activity of muscles in the trunk or head. This helps evaluate muscle and nerve function. |
11 | $60 | $225 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$44,445
Total received (2018-2024)
Avg $6,349/year across 7 years
Top 10% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
663
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$35,398 (79.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,048 (20.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,995
2023
$8,968
2022
$11,243
2021
$8,987
2020
$9,447
2019
$1,655
2018
$1,150
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
TG Therapeutics, Inc.
$504
ABBVIE INC.
$360
UCB, Inc.
$344
Biogen, Inc.
$173
ARGENX US, INC.
$141
SK Life Science, Inc.
$119
Alexion Pharmaceuticals, Inc.
$112
Lundbeck LLC
$108
PFIZER INC.
$103
Amgen Inc.
$90
Teva Pharmaceuticals USA, Inc.
$89
Neurelis, Inc.
$83
Mallinckrodt Hospital Products Inc.
$80
Ipsen Biopharmaceuticals, Inc
$78
Eisai Inc.
$75
Takeda Pharmaceuticals U.S.A., Inc.
$66
Novartis Pharmaceuticals Corporation
$60
CATALYST PHARMACEUTICALS, INC.
$58
MDD US Operations, LLC
$54
Lilly USA, LLC
$51
BANNER LIFE SCIENCES, LLC
$38
JAZZ PHARMACEUTICALS INC.
$31
Xeris Pharmaceuticals, Inc.
$25
HARMONY BIOSCIENCES LLC
$24
Neurocrine Biosciences, Inc.
$23
Sumitomo Pharma America, Inc.
$21
Averitas Pharma Inc.
$19
Otsuka America Pharmaceutical, Inc.
$18
Genentech USA, Inc.
$17
Kedrion Biopharma, Inc.
$16
Marinus Pharmaceuticals, Inc.
$16
Top 3 companies account for 40.3% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$13,567
ABBVIE INC.
$11,059
Allergan, Inc.
$10,969
UCB, Inc.
$791
EMD Serono, Inc.
$584
Novartis Pharmaceuticals Corporation
$563
TG Therapeutics, Inc.
$504
Sunovion Pharmaceuticals Inc.
$477
Amgen Inc.
$437
Alexion Pharmaceuticals, Inc.
$433
Biogen, Inc.
$352
Teva Pharmaceuticals USA, Inc.
$323
GENZYME CORPORATION
$271
ARGENX US, INC.
$269
PFIZER INC.
$268
Lundbeck LLC
$245
Allergan Inc.
$237
Lilly USA, LLC
$219
Neurocrine Biosciences, Inc.
$207
MDD US Operations, LLC
$192
SK Life Science, Inc.
$160
Supernus Pharmaceuticals, Inc.
$152
TG THERAPEUTICS, INC.
$143
Genentech USA, Inc.
$136
Mallinckrodt Hospital Products Inc.
$132
Ipsen Biopharmaceuticals, Inc
$126
Eisai Inc.
$118
Neurelis, Inc.
$112
LivaNova USA, Inc.
$108
Harmony Biosciences LLC
$82
ACADIA Pharmaceuticals Inc
$70
Greenwich Biosciences, Inc.
$67
CSL Behring
$66
Takeda Pharmaceuticals U.S.A., Inc.
$66
Scilex Pharmaceuticals Inc.
$63
CATALYST PHARMACEUTICALS, INC.
$58
BANNER LIFE SCIENCES, LLC
$57
Jazz Pharmaceuticals Inc.
$52
JAZZ PHARMACEUTICALS INC.
$50
Adamas Pharmaceuticals, Inc.
$47
HARMONY BIOSCIENCES LLC
$43
Otsuka America Pharmaceutical, Inc.
$42
Alnylam Pharmaceuticals Inc.
$39
Amneal Pharmaceuticals LLC
$31
ARBOR PHARMACEUTICALS, INC.
$30
US WorldMeds, LLC
$29
Biohaven Pharmaceuticals, Inc.
$28
Xeris Pharmaceuticals, Inc.
$25
Axsome Therapeutics, Inc.
$22
Sumitomo Pharma America, Inc.
$21
AbbVie, Inc.
$21
Catalyst Pharmaceuticals, Inc.
$21
E.R. Squibb & Sons, L.L.C.
$19
Averitas Pharma Inc.
$19
Horizon Therapeutics plc
$19
Janssen Pharmaceuticals, Inc
$19
GE HEALTHCARE
$18
Kyowa Kirin, Inc.
$17
Upsher-Smith Laboratories LLC
$17
Kedrion Biopharma, Inc.
$16
UPSHER-SMITH LABORATORIES LLC
$16
Marinus Pharmaceuticals, Inc.
$16
Biohaven Pharmaceutical Holding Company Ltd.
$15
Aprecia Pharmaceuticals, LLC
$15
Saol Therapeutics Inc.
$15
ANI Pharmaceuticals, Inc.
$15
Avanir Pharmaceuticals, Inc.
$14
Impax Laboratories, Inc.
$13
Top 3 companies account for 80.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMVUTTRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Albuked · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · COMIRNATY · DAYBUE · DUOPA · Duopa · Dysport · EMGALITY · EPIDIOLEX · Epidiolex · FIRDAPSE · FYCOMPA · Fintepla · GILENYA · GOCOVRI · Gocovri · HYQVIA · Hizentra · Horizant · INGREZZA · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · Leqembi · Lioresal (baclofen) · MAVENCLAD · MS DISEASE STATE · MYOBLOC · Mavenclad · NAMZARIC · NEXVIAZYME · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · OCREVUS · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PAXLOVID · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · REXULTI · RYTARY · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · Soliris · Spritam · Sunosi · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · UBRELVY · UPLIZNA · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · ZEPOSIA · ZTALMY · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for neurology in GA.
Geographic Context
Neurologists within 10 mi
26
Per 100K population
8.7
County median income
$69,575
Nearest hospital
COASTAL HARBOR TREATMENT CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fleenor is a mixed practice specialist, with above-average Medicare volume (top 10% in GA), with speaking/promotional industry engagement in the top 10% of GA peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fleenor experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Fleenor performed 11,045 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fleenor receive payments from pharmaceutical companies?
Yes. Dr. Fleenor received a total of $44,445 from 68 companies across 663 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fleenor's costs compare to other neurologists in Savannah?
Dr. Fleenor's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fleenor) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Savannah
Browse neurologists in Savannah ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology